All In MedTech

Device Trial Radar · NCT07844317

Pivotal Trial for an Automated AI-based System for Detection of Diabetic Retinopathy

A Multicenter, Prospective Clinical Trial to Evaluate the Safety and Efficacy of an Automated System for Detecting Diabetic Retinopathy Using a Fundus Camera

Last checked: Nov 19, 2026Latest source record: Sep 28, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

RecruitingPivotal-lookingTitle says "pivotal". This is a heuristic, not a regulatory label.

Status

Recruiting

Enrollment

800

Planned (sponsor's estimate)

Start

Aug 24, 2026

Primary completion

May 30, 2027

Study completion Aug 31, 2027

Sponsor

Lead sponsor
Digital Diagnostics, Inc.Not on our public-company list
Sponsor type
Industry
First posted
Sep 28, 2026

More device trials from this sponsor

Design

Study type
Observational
FDA-regulated device
No
Who can join
All sexes, from 22 years
Healthy volunteers
Yes

Summary

As written by the sponsor on the registry.

Assessment of an autonomous AI system for diabetic retinopathy detection in adults with diabetes using retinal imaging.

Conditions

  • Diabetic Retinopathy (DR)

Interventions

  • SaMD intended for the detection of diabetic retinopathy in adults with diabetes.Device

    No significant difference to other SaMDs for the detection of DR that are commercialized.

  • An AI/ML-based Software as a Medical Device (SaMD) for the automated detection of diabetic retinopathy in adults with diabetes.Device

    SaMD to detect diabetic retinopathy

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Evaluation of the safety and efficacy of an AI-based SaMD with a fundus camera for the detection of Diabetic RetinopathyTime frame: 1-year

Locations

1 site in 1 country. Site status is shown where the registry gives one.

  • Rovia Site Network

    Jacksonville, Florida · Recruiting

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.